Canonical ingredient

5H-Dibenz[b,f]azepine-5-propanamine, 3-chloro-10,11-dihydro-N,N-dimethyl-, monohydrochloride

CLOMIPRAMINE HYDROCHLORIDE

38 linked products

Official identifiers

CAS 17321-77-6 ChEBI CHEBI:3755 InChI InChI=1S/C19H23ClN2.ClH/c1-21(2)12-5-13-22-18-7-4-3-6-15(18)8-9-16-10-11-17(20)14-19(16)22;/h3-4,6-7,10-11,14H,5,8-9,12-13H2,1-2H3;1H InChIKey WIMWMKZEIBHDTH-UHFFFAOYSA-N SMILES CN(C)CCCN1c2ccccc2CCc2ccc(Cl)cc21.Cl

Names and synonyms

5H-Dibenz[b,f]azepine-5-propanamine, 3-chloro-10,11-dihydro-N,N-dimethyl-, monohydrochloride (en)
clomipramine hydrochloride (en)
Chlorhydrate de clomipramine (fr)
3-chloro-10,11-dihydro-N,N-diméthyl-5H-dibenz[b,f]azepine-5-propanamine, monochlorhydrate (fr-CA)

Source-scoped chemical properties

Every value keeps its own authority, licence and retrieval date. Conflicting values are not silently merged.

canada dsl listing: listed; canada_dsl_categorization · Open Government Licence - Canada 2.0 · 2026-08-03
dsl bioaccumulative: Yes; canada_dsl_categorization · Open Government Licence - Canada 2.0 · 2026-08-03
dsl inherently toxic aquatic: Yes; canada_dsl_categorization · Open Government Licence - Canada 2.0 · 2026-08-03
dsl meets cepa categorization: Yes; canada_dsl_categorization · Open Government Licence - Canada 2.0 · 2026-08-03
dsl meets environmental: Yes; canada_dsl_categorization · Open Government Licence - Canada 2.0 · 2026-08-03
dsl meets human health: No; canada_dsl_categorization · Open Government Licence - Canada 2.0 · 2026-08-03
dsl persistent: Yes; canada_dsl_categorization · Open Government Licence - Canada 2.0 · 2026-08-03
dsl substance category: Organics; canada_dsl_categorization · Open Government Licence - Canada 2.0 · 2026-08-03

Safety and technical documents

General references and manufacturer-specific SDS documents are kept separate.

0 document(s)

No verified SDS or technical sheet is linked yet. This absence is explicit and does not mean that no document exists.

End-to-end traceability

Only links supported by an identified source are published. Missing evidence remains explicitly unknown.

Partial chain

Evidence still missing

Country or region of origin
Raw-material producer
Ingredient manufacturer
Distributor
Transformation steps

Documented origins

No origin has been proven yet by an explicit source.

Documented organizations

No organization has been proven yet by an explicit source.

Documented transformations

No transformation step has been proven yet by an explicit source.

Method: a company’s registration country is never used as evidence of a material’s origin.

Products containing this ingredient

ACT CLOMIPRAMINE

ACT CLOMIPRAMINE

ACT CLOMIPRAMINE

ALTIUS-CLOMIPRAMINE

ALTIUS-CLOMIPRAMINE

ALTIUS-CLOMIPRAMINE

APO-CLOMIPRAMINE

APO-CLOMIPRAMINE

APO-CLOMIPRAMINE

CLOMIPRAMINE TABLETS 10MG

CLOMIPRAMINE TABLETS 25MG

CLOMIPRAMINE TABLETS 50MG

CLOMIPRAMINE-10 - TAB 10MG

CLOMIPRAMINE-25 - TAB 25MG

CLOMIPRAMINE-50 - TAB 50MG

DOM-CLOMIPRAMINE

DOM-CLOMIPRAMINE

GEN-CLOMIPRAMINE - TAB 10MG

GEN-CLOMIPRAMINE - TAB 25MG

GEN-CLOMIPRAMINE - TAB 50MG

MED CLOMIPRAMINE TABLETS - 25MG

MED CLOMIPRAMINE TABLETS - 50MG

NOVO-CLOPAMINE TAB 10MG

NOVO-CLOPAMINE TABLETS - 25MG

NOVO-CLOPAMINE TABLETS- 50MG

PENTA-CLOMIPRAMINE - 25MG

PENTA-CLOMIPRAMINE - 50MG

PMS-CLOMIPRAMINE

10 · MG · TAB

PMS-CLOMIPRAMINE

25 · MG · TAB

PMS-CLOMIPRAMINE

50 · MG · TAB

TARO-CLOMIPRAMINE

TARO-CLOMIPRAMINE